维普中文期刊产品整合服务
19篇 您的检索式:作者名="TENG LS"
    题名 作者 年代 出处 被引量
1Survival factors after resection of small hepatocellular carcinoma显示文摘Early resection of hepatocellular carcinoma is a key measure to prolong the survival of patients. This study was designed to summarize our experience in surgical resection of small hepatocellular carcinoma (HCC), and to analyze the factors influencing the postoperative survival of patients. METHODS:The clinicopathologic data of 105 patients with small HCC after resection from 1986 through 2003 were analyzed ; the patients had been followed up for more than half a year (median 33 months). Nine clinicopathologic factors, preoperative α-fetoprotein (AFP) level, liver cirrhosis, Child-Pugh score, tumor size (>2cm vs.≤2 cm) and number (single vs. multiple), capsule formation, portal vein tumor thrombi (PVTT), Edmondson tumor grade and surgical method, were analyzed by the log-rank test and the Cox proportional harzards model analysis. RESULTS:The cumulative 1-,3- and 5-year survival rates after the operation were 86.5%, 70.3% and 55.2%, respectively, and the 1-, 3- and 5-year disease-free survival rates were 78%, 58. 9% and 45. 6%, respectively. One patient died from esophagogastric varices hemorrhage in 2 weeks after reoperation. Thirty-six patients had intrahepatic recurrence or metastasis postoperatively and 34 patients died. The Kaplan-Meier method and the Cox proportional harzards model analysis indicated that poor Child-Pugh score, tumor more than 2 cm in diameter, PVTT and multiple lesions (including satellitic lesions) were adverse factors affecting postoperative survival. The Cox proportional harzards model analysis indicated that tumor size, PVTT and multiple lesions were the factors influencing postoperative disease-free survival. CONCLUSIONS:Limited hepatectomy with a margin more than 1 cm is an appropriate surgical approach. Adverse preoperative Child-Pugh score and postoperative intrahepatic recurrences are the main factors leading to the death of patients with small HCC.Departments of Surgical Oncology (Wu FS, Zhao WH, Ma ZM, Teng LS and Wang M) and General Surgery ( Liang TB and Zheng SS) , First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China 2005Hepatobiliary & Pancreatic Diseases International2005,4,3:5
2Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatoeellular carcinoma (HCC) after hepateetomy 显示文摘Ma WJ Wang HY Teng LS 2013World J Surg Oneol2013,11,:1
3Clinical Applications of VEGF-Trap(Aflibercept) in Cancer Treatment显示文摘Teng LS Jin KT He KF 2010Chin Med Assoc2010,73,9:1
4Efficient cytosolic delivery mediated by polymersomes facilely prepared from a degradable, amphiphilic, and amphoterie copolymer显示文摘Huang ZH Teng W Liu LS 2013Nanotechnology2013,24,26:1
5Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepayocellar carcinoma (HCC) after hepatectomy显示文摘Ma WJ Wang HY Teng LS 2013Word J Surg Oncol2013,11,:1
6Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment显示文摘Teng LS Jin KT He KF 0,,06:1
7Conservative management ofrecurrent bilateral ovarian cysts in pregnancy:a case report显示文摘Teoh SH Teoh LS Teng WC 2003Singapore Med J2003,44,10:1
8Advances in combination ofantiangiogenic agents targeting VEGF-binding and conventionalchemotherapy and radiation for cancer treatment显示文摘Teng LS Jin KT He KF 2010Journal of theChinese Medical Association2010,73,6:1
9Advances in combination of antiangiogenic agents targeting VEGF-binding and con- ventional chemotherapy and radiation for cancer treatment 显示文摘Teng LS Jin KT He KF 2010J Chin MedAssoc2010,73,6:1
10Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment 显示文摘Teng LS Jin KT He KF 2010J Chin Med Assoc2010,73,6:1
11Aflibercept (VEGF Trap) : one more double-edged sword of anti-VEGF therapy for cancer? 显示文摘Teng LS Jin KT He KF 2010J Chin MedAssoc2010,73,9:1
12Biodegradable poly (D, L- lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone : Zero-order release formulation 显示文摘SU ZX SHI YN TENG LS 2011Pharm Dev Technol2011,16,4:1
13BRCA1/2 associated hereditary breast cancer显示文摘 Zheng Y Wang HH 2006Surg Oncol2006,9,2:1
14Clinical applications of VEGF-Trap (aflibercept) in cancer treatment显示文摘Teng LS Jin KT He KF 0,,09:1
15Interventional radiology in China 显示文摘Teng GJ Xu K Li LS 2008Cardiovasc Intervent Radiol2008,31,:1
16Advances in combination of antiangiogenic agents targeting VEGF-hinding and conventional chemotherapy and radiation for cancer treatment显示文摘Teng LS Jin KT He KF 2010J Chin Med Assoc2010,73,6:1
17Advances in combination of antiangiogenic agents targeting VEGF-binding and con- ventional chemotherapy and radiation for cancer treatment 显示文摘Teng LS Jin KT He KF 2010J Chin Med Assoc2010,73,6:1
18Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment 显示文摘TENG LS JIN KT HE KF 2010J Chin Med Assoc2010,73,6:1
19Clinical applications of VEGF-trap(aflibercept)in cancer treatment显示文摘Teng LS Jin KT He KF 2010J Chin Med Assoc2010,73,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费